FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975712964> ?p ?o ?g. }

• W1975712964 abstract "The soluble interleukin-2 receptor (sIL-2R, sIL2R, sTAC, sCD25) is a reliable biomarker for disease activity in inflammatory disorders such as sarcoidosis. Based on the essential pathogenic role of inflammation for progression of liver diseases, we hypothesized that sIL-2R might be an indicator of inflammatory cell activation and disease severity in patients with chronic liver diseases (CLD).We measured sIL-2R serum levels in 71 patients with different stages and etiologies of CLD in comparison to 41 healthy controls. Serum sIL-2R concentrations were correlated with laboratory markers of liver diseases, cytokine / chemokine levels and circulating immune cell subpopulations as simultaneously assessed by FACS analysis from peripheral leukocytes.CLD patients showed significantly elevated serum sIL-2R levels compared with controls. sIL-2R was significantly higher in patients with compared to patients without established liver cirrhosis and increased with the Child-Pugh stage of cirrhosis, independent of the underlying etiology. sIL-2R levels correlated inversely with parameters indicating the hepatic biosynthetic capacity, such as albumin or international normalized ratio, and positively with non-invasive markers of liver fibrosis such as hyaluronic acid or procollagen-III-peptide. Circulating immune cells might represent a major source of sIL-2R. In fact, sIL2-R levels correlated closely with circulating monocytes, especially non-classical CD14+ CD16+ monocytes, which were found to express high levels of CD25 by FACS. Pro-inflammatory cytokines, including IL-2, IFNγ or IL-6, and chemokines were also associated with sIL2-R. In addition, renal failure was an important confounder of sIL-2R levels independent of liver dysfunction and inflammation.sIL-2R is elevated in patients with liver diseases and cirrhosis, is associated with circulating inflammatory cells and is increased in concomitant renal failure. These data indicate that sIL-2R might be a potential marker for immune cell activation in CLD, especially for proinflammatory and profibrogenic non-classical CD14 + CD16+ monocytes." @default.
• W1975712964 created "2016-06-24" @default.
• W1975712964 creator A5006242340 @default.
• W1975712964 creator A5017138397 @default.
• W1975712964 creator A5055719124 @default.
• W1975712964 creator A5083825910 @default.
• W1975712964 creator A5089162876 @default.
• W1975712964 date "2012-04-24" @default.
• W1975712964 modified "2023-10-13" @default.
• W1975712964 title "Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes" @default.
• W1975712964 cites W1506157243 @default.
• W1975712964 cites W1512843295 @default.
• W1975712964 cites W1535854559 @default.
• W1975712964 cites W1540459294 @default.
• W1975712964 cites W1965557074 @default.
• W1975712964 cites W1983273003 @default.
• W1975712964 cites W1984452374 @default.
• W1975712964 cites W1987344938 @default.
• W1975712964 cites W1992335645 @default.
• W1975712964 cites W2010903159 @default.
• W1975712964 cites W2014198428 @default.
• W1975712964 cites W2014980326 @default.
• W1975712964 cites W2024756114 @default.
• W1975712964 cites W2031219794 @default.
• W1975712964 cites W2041646069 @default.
• W1975712964 cites W2048466125 @default.
• W1975712964 cites W2051785701 @default.
• W1975712964 cites W2058743791 @default.
• W1975712964 cites W2067475593 @default.
• W1975712964 cites W2072150914 @default.
• W1975712964 cites W2074118570 @default.
• W1975712964 cites W2076934547 @default.
• W1975712964 cites W2077228061 @default.
• W1975712964 cites W2083811181 @default.
• W1975712964 cites W2127022844 @default.
• W1975712964 cites W2132828093 @default.
• W1975712964 cites W2133811759 @default.
• W1975712964 cites W2136311148 @default.
• W1975712964 cites W2138966960 @default.
• W1975712964 cites W2140270007 @default.
• W1975712964 cites W2155826396 @default.
• W1975712964 cites W2157953677 @default.
• W1975712964 cites W2325679751 @default.
• W1975712964 cites W4250007760 @default.
• W1975712964 doi "https://doi.org/10.1186/1471-230x-12-38" @default.
• W1975712964 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3434055" @default.
• W1975712964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22530792" @default.
• W1975712964 hasPublicationYear "2012" @default.
• W1975712964 type Work @default.
• W1975712964 sameAs 1975712964 @default.
• W1975712964 citedByCount "48" @default.
• W1975712964 countsByYear W19757129642013 @default.
• W1975712964 countsByYear W19757129642014 @default.
• W1975712964 countsByYear W19757129642015 @default.
• W1975712964 countsByYear W19757129642016 @default.
• W1975712964 countsByYear W19757129642017 @default.
• W1975712964 countsByYear W19757129642018 @default.
• W1975712964 countsByYear W19757129642019 @default.
• W1975712964 countsByYear W19757129642020 @default.
• W1975712964 countsByYear W19757129642021 @default.
• W1975712964 countsByYear W19757129642022 @default.
• W1975712964 countsByYear W19757129642023 @default.
• W1975712964 crossrefType "journal-article" @default.
• W1975712964 hasAuthorship W1975712964A5006242340 @default.
• W1975712964 hasAuthorship W1975712964A5017138397 @default.
• W1975712964 hasAuthorship W1975712964A5055719124 @default.
• W1975712964 hasAuthorship W1975712964A5083825910 @default.
• W1975712964 hasAuthorship W1975712964A5089162876 @default.
• W1975712964 hasBestOaLocation W19757129641 @default.
• W1975712964 hasConcept C126322002 @default.
• W1975712964 hasConcept C203014093 @default.
• W1975712964 hasConcept C2776090121 @default.
• W1975712964 hasConcept C2776914184 @default.
• W1975712964 hasConcept C2777075537 @default.
• W1975712964 hasConcept C2777214474 @default.
• W1975712964 hasConcept C2778513237 @default.
• W1975712964 hasConcept C2778690821 @default.
• W1975712964 hasConcept C2779102576 @default.
• W1975712964 hasConcept C71924100 @default.
• W1975712964 hasConcept C79484868 @default.
• W1975712964 hasConcept C8891405 @default.
• W1975712964 hasConceptScore W1975712964C126322002 @default.
• W1975712964 hasConceptScore W1975712964C203014093 @default.
• W1975712964 hasConceptScore W1975712964C2776090121 @default.
• W1975712964 hasConceptScore W1975712964C2776914184 @default.
• W1975712964 hasConceptScore W1975712964C2777075537 @default.
• W1975712964 hasConceptScore W1975712964C2777214474 @default.
• W1975712964 hasConceptScore W1975712964C2778513237 @default.
• W1975712964 hasConceptScore W1975712964C2778690821 @default.
• W1975712964 hasConceptScore W1975712964C2779102576 @default.
• W1975712964 hasConceptScore W1975712964C71924100 @default.
• W1975712964 hasConceptScore W1975712964C79484868 @default.
• W1975712964 hasConceptScore W1975712964C8891405 @default.
• W1975712964 hasIssue "1" @default.
• W1975712964 hasLocation W19757129641 @default.
• W1975712964 hasLocation W19757129642 @default.
• W1975712964 hasLocation W19757129643 @default.
• W1975712964 hasLocation W19757129644 @default.
• W1975712964 hasLocation W19757129645 @default.
• W1975712964 hasOpenAccess W1975712964 @default.

• next